Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of minocycline and hydroxychloroquine that has shown unexpected additive effects in treating various conditions. Minocycline is an antibiotic in the tetracycline family with anti-inflammatory properties, while hydroxychloroquine is an antimalarial drug commonly used for autoimmune conditions. The combination has demonstrated synergistic effects in experimental models of multiple sclerosis, with potential applications in rheumatoid arthritis and COVID-19. The mechanism involves combined inhibition of microglia, modulation of T-cell and B-cell proliferation, iron neurotoxicity reduction, and anticytokine effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on minocycline + hydroxychloroquine.